10x Genomics, Inc. Total Contract Liability
10x Genomics, Inc. (TXG) had Total Contract Liability of $33.29 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-07
- 2026-06-30: Contract with Customer, Liability $33.29M.
- 2026-03-31: Contract with Customer, Liability $34.48M.
- 2025-12-31: Contract with Customer, Liability $34.40M.
- 2025-09-30: Contract with Customer, Liability $33.00M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-06-30 | $33.29M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $34.48M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $34.40M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $33.00M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $33.52M 10-Q · filed 2026-08-07 | $32.70M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $33.52M 10-Q · filed 2026-05-08 | $33.50M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $33.17M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $30.10M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $27.80M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $24.10M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $21.96M 10-K · filed 2026-02-13 | |
| 2023-09-30 | $17.70M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $13.90M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $12.10M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $11.03M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $9.40M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $9.30M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $7.90M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $7.69M 10-K · filed 2024-02-15 | |
| 2021-09-30 | $7.30M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $6.90M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $6.10M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $6.15M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $5.00M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $4.60M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $4.60M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $4.13M 10-K · filed 2022-02-18 | |
| 2019-09-30 | $4.30M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $3.50M 10-K · filed 2021-02-26 |